GGrantIndex
Sort

35,931 grants matching parkinsons

Elucidating the regulation and function of amyloid-like assemblies

$449,473
Luke E Berchowitz · Columbia University Health Sciences · R35 · FY2022 · GM

Methods for Dynamic Causal Interactions in Human Brain Function and Dysfunction

$449,410
Vinod Menon · Stanford University · R01 · FY2014 · NS

Next Generation Drugs for Bipolar Depression and Maintenance

$449,400
Thomas H Large · Blue Oak Pharmaceuticals, Inc. · R43 · FY2019 · MH

Next Generation Drugs for Bipolar Depression and Maintenance

$449,400
Thomas H Large · Blue Oak Pharmaceuticals, Inc. · R43 · FY2018 · MH

Molecular Mechanisms of Prion Protein Amyloid Formation

$449,373
Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Tau seeding and strains in the clinicopathologic heterogeneity of Alzheimer disease

$449,333
Trung Phuoc Nguyen · Ut Southwestern Medical Center · R21 · FY2020 · AG

Attention and Executive Functioning in Aging and Parkisonism

$449,283
Jay S Schneider · Thomas Jefferson University · R01 · FY2009 · NS

MGE Progenitor Cell Grafts and Epilepsy

$449,269
Scott Charles Baraban · University Of California, San Francisco · R01 · FY2007 · NS

Parkinsonism-Related Changes in Activity of Cortical Projection Neurons in Monkeys

$449,260
Adriana Galvan · Emory University · P50 · FY2021 · NS

Dopamine, Synaptic Plasticity and Striatal Ensemble Dynamics Underlying Motor Learning

$449,246
Jones G Parker · Northwestern University At Chicago · R01 · FY2022 · NS

Dopamine, Synaptic Plasticity and Striatal Ensemble Dynamics Underlying Motor Learning

$449,246
Jones G Parker · Northwestern University At Chicago · R01 · FY2025 · NS

Development of a benchtop x-ray fluorescence tomography system using a novel geom

$449,241
Patrick Jean La Riviere · University Of Chicago · R01 · FY2015 · EB

Development of a Novel Chemokine Receptor Antagonist Peptide as a Synapse Protecting Treatment for Neurodegeneration in Alzheimer's Disease

$449,230
Michael R Ruff · Creative Bio-Peptides, Inc. · R43 · FY2020 · AG

Health Effects Of Exposures In Agriculture

$449,205
Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES

Determining the role of AR transcriptional function in SBMA

$449,191
Diane E Merry · Thomas Jefferson University · R01 · FY2019 · NS

Molecular Mechanism of LRRK2 Biology and Pathology in Parkinson's Disease

$449,073
Zhenyu Yue · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · NS

Structure and Function of NMDA Receptors

$449,064
Hiroyasu Furukawa · Cold Spring Harbor Laboratory · R01 · FY2013 · MH

PET Imaging MDMA Neurotoxicity

$449,061
Johns Hopkins University · R01 · FY2002 · DA

Dynamics of Posture and Reaching

$449,061
James R Lackner · Brandeis University · · FY2014 · SBE

Midbrain Mechanisms of Sensory-Guided Oculomotor Choice

$449,049
Terrence R Stanford · Wake Forest University Health Sciences · R01 · FY2015 · EY

Programming age in iPS models of Alzheimer's disease

$449,000
Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2021 · AG

Programming age in iPS models of Alzheimer's disease

$449,000
Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2019 · AG

Programming age in iPS models of Alzheimer's disease

$449,000
Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2020 · AG

Molecular Segregation of Parkinson’s Disease by Patient-derived Neurons

$448,985
Jian Feng · State University Of New York At Buffalo · R01 · FY2022 · NS

Molecular Segregation of Parkinson’s Disease by Patient-derived Neurons

$448,985
Jian Feng · State University Of New York At Buffalo · R01 · FY2020 · NS